Filing Details

Accession Number:
0001209191-22-031672
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-24 17:13:48
Reporting Period:
2022-05-20
Accepted Time:
2022-05-24 17:13:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1496323 Igm Biosciences Inc. IGMS Pharmaceutical Preparations (2834) 770349194
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1785882 Haldor Jakob Topsoe C/O Igm Biosciences, Inc.
325 E. Middlefield Road
Mountain View CA 94043
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-20 1,481 $16.00 73,462 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 10,400,564 Indirect See footnote
Footnotes
  1. The shares are held directly by Topsoe Holding A/S (formerly Haldor Topsoe Holding A/S). Jakob Haldor Topsoe, Christina Teng Topsoe, Anne Haugwitz-Hardenberg-Reventlow, Emil Oigaard, Thomas Schleicher and Birgitte Nielsen, members of the board of directors of Topsoe Holding A/S, may be deemed to share voting and investment power with respect to the shares reported herein and disclaim beneficial ownership of such shares, except to the extent of his or her pecuniary interest therein, if any.